High-throughput screening identifies NT-1 that synergizes with MRTX1133 against acquired resistant KRAS G12D colorectal cancer
Publisher
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: npj Precision Oncology
Scope: Research
Related coverage
More related coverage
Digital upgrade to histopathology service reduces wait time for cancer diagnosis
State-of-the-art scanners and advanced image management software allow for more efficient service.
Identification of biomarkers for non-invasive diagnosis and risk stratification in prostate cancer using NMR-based metabolomics and machine learning
South Suburban Pastor Returns to His Ministry One Month After First-of-its-Kind Lung Cancer Surgery at Northwestern Medicine
Cytalux, an imaging agent that illuminates cancer cells, enables more precise tumor removal
Signs You May Need a New Pillow
Cleveland Clinic, a non-profit academic medical center, provides clinical and hospital care and is a...